🚀 RECENT AI SUCCESS

Our AI successfully predicted the gap for $SWBI and executed a BUY strategy, securing a +116.95% net profit.

UPGRADE TO SEE LIVE SIGNALS

$UCB.BR

UCB SA

European UnionEUROPEAN UNION
FREE PREVIEW
AVG HISTORICAL GAP-3.60%
MAX GAP RECORD-3.60%
PREMIUM
AI ACCURACY RATE
92.4%
Unlock AI Insights 🔓

LAST 10 EARNINGS GAPS (%)

VOLATILITY & BIAS PROFILE

AVG VOLATILITY3.6%
Bullish Gaps
Bearish Gaps
Neutral

Intelligence Brief

UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium. Read full dossier

CURRENT AI SIGNAL
BULLISH STRONG
🔓 REVEAL SIGNAL